2024 Conference Programme

All children and young people presenting with cancer in England are now eligible for whole genome sequencing on the NHS. Here we will present the experience of two centres who were early adopters of routine WGS, alongside results from our study assessing it's clinical value when compared with current standard of care molecular testing.

Christen and Lisa found themselves in a space they didn’t quite belong – they joined forces, to create a charity and community, for others with genetic alterations. You have your medical professionals to talk about surgery, recovery, pain meds. You have BRCA+ Chat to talk to you about T-Rex arms, wiping your butt, and delving into dating with no nipples and night sweats. From cold implants, to a warm heart – BRCA+ Chat scoops you up, like the little hug you needed. Find out more about the lived experience of a genetic alteration, and the charity that was formed by two women who met on social media.

Pharmacogenomics has the potential to transform how medicines are prescribed. We will discuss our experience of implementing pharmacogenomics in two pilot projects. Both projects focussed on mental he ...

Dr Reyal, a consultant haematologist, will explore the issue of delayed diagnosis of myeloma and highlight its impact on patients. You will also hear from Sue, a myeloma patient, who experienced life- ...

This promotional symposium has been organised and funded by Novartis Pharmaceuticals UK Ltd and is intended for UK Healthcare Professionals only. Novartis products will be discussed at this meeting an ...

Understanding the signs of Head & Neck Cancer could save your life, do you know the signs?

This session will aim to not only discuss the difficulties that can be experienced with communities that are known to be at high risk of developing prostate cancer, but also those communities who may not be at greater risk but are often not thought about sufficiently and are this at risk of not being aware of the need to be tested when appropriate.

What to expect and how to deliver a PCa Health Check event with success

Implementation of liquid biopsies to detect relapse earlier in head and neck cancer

opening the planned session

In this presentation, I will delve into the transformative potential of CAR T cell therapy in the field of solid tumours. Beginning with an overview of CAR T cell therapy and its impact on cancer treatment, I will navigate through the distinct challenges posed by solid tumours, including their heterogeneity and the complexities of the tumour microenvironment. I will spotlight breakthroughs in preclinical and clinical trials demonstrating the feasibility and efficacy of CAR T cells against solid tumours, while also addressing toxicity considerations. This presentation also explores strategies to enhance CAR T cell efficacy within the tumour microenvironment. Looking ahead, I will describe the potential future of CAR T cell therapy in solid tumours with optimisation through collaborative efforts, innovative designs, and combination therapies.

This session will focus on how self-administration of Breast Cancer treatments can improve capacity and patient experience

Future session content to be announced...

In 2022 Macmillan undertook a survey of cancer nurses with 199 respondents. The knowledge and education questions have been further analysed to understand needs. Macmillan developed a practical guide to support cancer nurses with the genomics toolkit and have worked with the NHSE national genomics education team to share the content. The session will cover the results of the survey and how they informed the development of the toolkit, what is included in the toolkit, as well as next steps for the toolkit.

Background in the development of the National Genomics Medicine Service and future directions in clinical cancer genomics.

as above

A multi-disciplinary approach to immunotherapy for older cancer patients involves a collaborative team of healthcare professionals, including oncologists, geriatricians, nurses, pharmacists, dieticians, occupational therapists, physiotherapists and other AHPs. This method is essential for addressing the unique physiological and psychological needs of older patients. The team tailors treatment plans to individual health conditions, manages side effects, and provides comprehensive support, encompassing medical, nutritional, and emotional care.

.

In this session, speakers discuss the clinical considerations essential for effective consultations and prescribing in transgender individuals living with cancer.  The session delves into creating a s ...

closing and reflecting on session

This session will cover the fundamentals of Radiotherapy Pre-Treatment, providing insight into what is involved in the process for the patient as well as how this service integrates with the wider mul ...

This session seeks to improve understanding of the radiotherapy planning pathway by giving an overview of what’s involved, and highlighting key innovations and their significance from the patient’s pe ...

Radiotherapy is a common treatment for many different cancers, using radiation. Although the treatment is highly targeted, there are side effects associated with the treatment due to some normal tissu ...

The use of SGRT to improve patient experience and provide a patient perspective of radiotherapy treatment.

The talk will aim to disucss the requirments and history of immobilisation in head and neck cancer.I will cover thermoplastics and the key features of the Orfit range and how it fits in to modern radi ...

Cancer patients in the UK urgently need a National Plan for Radiotherapy. This report sets out an ambitious but realistic vision to show what can be achieved over the next decade, transform radiothera ...

Exploration of the brachytherapy techniques Guy's and St Thomas' Hospital have been using, and those that have been implemented over the past 2 years.

Answering questions about my brachytherapy experience.

A discussion around consultant practice: the highs and the challenges, along with advice for people aspiring to become a consultant in their field

H

In this session Rachel Fay will talk about her daughter Gemma who sadly died in July 2023.

Breast Cancer treatment involves multiple appointments, procedures, and treatments within medical environments alongside multiple interactions with healthcare professionals. Research has shown that ba ...

Cancer is a disease of ageing. Therefore, the management of older adults is a crucial part of the routine practice for the cancer workforce. Nonetheless, several gaps of knowledge exist in geriatric o ...

This session will demonstrate how photobiomodualtion therapy and holistic supportive multi-disciplinary care can improve the quality of life by reducing the impact of radiotherapy late effects.

Navigating information around nutrition, diet, physical activity, and body weight for those living with and beyond cancer can be challenging and knowing when and how to provide this support even more ...

To increase awareness within the oncology multi-disciplinary team of the importance of early and high protein nutrition intervention in patients with cancer.

This presentation will showcase Penny Brohn UK’s online Treatment Support Programme which helps people learn how to incorporate lifestyle medicine and complementary support safely and appropriately wh ...

Support tailored to the individual is recognised as important for improving quality of life and wellbeing for people who have had treatment for breast cancer. This session will focus on the primary br ...

Integrative Oncology is an evolving evidence-informed field of medicine with little high-quality professional literature currently available to support clinical practice. Breast cancer is the commones ...

At Blood Cancer UK, we are running a project which aims to understand better attitudes towards, and barriers to, accessing clinical trials specifically amongst diverse ethnic communities. Based on our ...

The SURECAN study (Survivors’ Rehabilitation Evaluation after Cancer) is a £2.7 million programme grant funded by the National Institute for Health Research (NIHR) which evaluates a new ty ...